🇺🇸 FDA
Patent

US 9428750

Oligomeric compounds comprising tricyclic nucleosides and methods for their use

granted A61KA61K31/7042A61K31/7052

Quick answer

US patent 9428750 (Oligomeric compounds comprising tricyclic nucleosides and methods for their use) held by Ionis Pharmaceuticals, Inc. expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7042, A61K31/7052, A61K31/7088, A61K31/712